A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis

Simple item page
dc.contributor.authorLuis Valda Rodriguez
dc.contributor.authorJean-Pierre Dedet
dc.contributor.authorVirginia Paredtes
dc.contributor.authorCristo A Carrasco Mendoza
dc.contributor.authorFernando Cárdenas
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:44:03Z
dc.date.available2026-03-22T14:44:03Z
dc.date.issued1995
dc.descriptionCitaciones: 25
dc.description.abstractA randomized trial of amphotericin B (AB) alone and in combination with oral itraconazole (IZ) is carried out in two groups of 10 mucocutaneous leishmaniasis patients from Bolivia and Peru. AB+IZ combination is no better than AB monotherapy, as far as efficacy and tolerability are concerned. No antagonism was detected.
dc.identifier.doi10.1590/s0074-02761995000400020
dc.identifier.urihttps://doi.org/10.1590/s0074-02761995000400020
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/48232
dc.language.isoen
dc.publisherInstituto Oswaldo Cruz, Ministério da Saúde
dc.relation.ispartofMemórias do Instituto Oswaldo Cruz
dc.sourceInstituto Boliviano de Ciencia y Tecnología Nuclear
dc.subjectItraconazole
dc.subjectTolerability
dc.subjectAmphotericin B
dc.subjectLeishmaniasis
dc.subjectMedicine
dc.subjectMucocutaneous zone
dc.subjectRandomized controlled trial
dc.subjectAntagonism
dc.subjectDermatology
dc.subjectInternal medicine
dc.titleA randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis
dc.typearticle

Files

Collections

Artículo Científico Publicado